Evidence From Old Tumors Foretells Which New Breast Cancer Patients Will RequireAdditional Treatment

A rare medical archive -- which combines preserved breast cancer tissues with long-term follow-up information on each patient -- has enabled researchers from the University of Chicago Medical Center to determine how precisely two tumor characteristics can predict which breast cancers are likely to spread. They found that patients whose tumors had high levels of the product of a gene family called nm23 (for non-metastasis) and low density of newly formed blood vessels were far more likely to be alive 14 years after treatment. Further multi-variate analysis showed that nm23 and vessel density were "the most important tumor characteristics predicting outcome."

This report, in the July 1 issue of Cancer Research, is the largest study ever completed of node-negative breast cancer patients who received no adjuvant treatment -- radiation, hormone or chemotherapy after surgery -- and have been followed long enough to fully express the malignant potential of the disease.

While 91 percent of patients with high nm23 were alive an average of 14 years after treatment, only 70 percent of those with low nm23 survived that long. The lack of angiogenesis -- growth of new blood vessels to supply the budding tumor -- was an equally valid predictor; 92 percent of patients with a low micro-vessel count (MVC) survived at least 14 years versus only 70 percent of those with a high vessel density.

"Our study provides the best clues to date about how to treat patients with node-negative breast cancers, the kind we try to find with mammography," said first author Ruth Heimann, M.D., Ph.D., professor of radiation and cellular oncology at the University of Chicago. "We hope to use these data in our efforts to devise an individualized treatment plan for each patient, to separa

Contact: John Easton
773 702 6241
University of Chicago Medical Center

Page: 1 2 3

Related biology news :

1. Evidence builds for potential new cancer drug target
2. Evidence for sympatric speciation by host shift in the sea
3. Evidence for the impact of climate change on deep-sea biodiversity
4. Evidence for fat hormone target in brain
5. Evidence of nanobacterial-like structures found in human calcified arteries and cardiac valves
6. Evidence shows the heart has stem cells able to regenerate muscle tissue lost to disease, wear
7. Evidence for orangutan culture
8. Evidence suggests that standard smallpox vaccine offers long-term immunity
9. Evidence that adults stem cells differentiate like embryonic stem cells published in Nature
10. When Shewanella meets goethite: Evidence found of recognition between animate and inanimate objects
11. Evidence links protein damage to Parkinsons

Post Your Comments:

(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: